Diagnosing HIV-Related disease

Using the CD4 count as a guide
  • Alan C. Jung
  • Douglas S. Paauw
Clinical Review

Abstract

OBJECTIVE: To summarize current information on the relation between CD4 counts and the risk of different HIV-related diseases.

MEASUREMENTS AND MAIN RESULTS: MEDLINE search of English language articles between 1985 and 1996 using the medical subject heading (MeSH) term “CD4 lymphocyte count” and searches using key words of multiple HIV-related diseases were conducted. Some HIV-related diseases can be stratified to different CD4 count levels. Regardless of their CD4 count, HIV-infected patients are susceptible to sinusitis, Kaposi’s sarcoma, community-acquired pneumonia, and oral hairy leukoplakia. In advanced HIV, when CD4 is below 200/mm3, Pneumocystis carinii pneumonia, toxoplasmosis, progressive multifocal leukoencephalopathy, Mycobacterium avium complex, molluscum contagiosum, and bacillary angiomatosis all increase in incidence. In very advanced HIV disease, when CD4 counts are below 50/mm3, patients are at risk of pseudomonas pneumonia, cytomegalovirus retinitis, central nervous system lymphoma, aspergillosis, and disseminated histoplasmosis.

Summary

Regardless of their CD4 count, HIV-infected patients are susceptible to sinusitis, community-acquired pneumonia, oral hairy leukoplakia, Kaposi’s sarcoma, and HIV meningitis. Once their CD4 counts drop below 500/mm3, they are at risk of developing tuberculosis, thrush, herpes simplex, and herpes zoster. In advanced HIV, when their CD4 counts are below 200/mm3, PCP, coccidioidomycosis, bacillary angiomatosis, molluscum contagiosum, cryptococcal meningitis, toxoplasmosis, progressive multifocal leukoencephalopathy, Mycobacterium avium complex, and non-Hodgkin’s lymphoma all increase in incidence. In very advanced HIV, when their CD4 counts are below 50/mm3, they are at risk of pseudomonas pneumonia, CMV retinitis, CNS lymphoma, aspergillosis, and histoplasmosis. By appreciating these characteristic changes in disease incidence, and by knowing a patient’s CD4 count, clinicians should be better able to develop differential diagnoses and plans for diagnostic evaluation.

Key words

CD4 count HIV-related disease risk stratification 

References

  1. 1.
    Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of the virus in plasma. Science. 1996;272:1167–70.PubMedCrossRefGoogle Scholar
  2. 2.
    A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J. Acquir Immune Defic Syndr Hum Retrovirol. 1996; 13(1):23–6.Google Scholar
  3. 3.
    Baroud JM, Haley L, Montaner JS, Murphy C, Januszewska M, Schechter MT. Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals. J Acquir Immune Defic Syndr. 1995;10(suppl 2):S67–73.Google Scholar
  4. 4.
    Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis. 1994;169:28–36.PubMedGoogle Scholar
  5. 5.
    Turner BJ, Hecht FM, Ismail RB. CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. Arch Intern Med. 1994;154:1561–73.PubMedCrossRefGoogle Scholar
  6. 6.
    Holmberg SD, Buchbinder SP, Conley LJ, et al. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus. Am J Epidemiol. 1995;141:395–404.PubMedGoogle Scholar
  7. 7.
    Godofsky EW, Zinreich J, Armstrong M, Leslie JM, Weikel CS. Sinusitis in HIV-infected patients: a clinical and radiographic review. Am J Med. 1992;93:163–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Zurlo JJ, Feuerstein IM, Lebovics R, Lane HC. Sinusitis in HIV-1 infection. Am J Med. 1992;93:157–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Milgram LM, Rubin JS, Rosenstreich DL, Small CB. Sinusitis in human immunodeficiency virus infection, typical and atypical organisms. J Otolaryngol. 1994;23:450–3.Google Scholar
  10. 10.
    Tami TA. The management of sinusitis in patients infected with the human immunodeficiency virus (HIV). Ear Nose Throat J. 1995;74:360–3.PubMedGoogle Scholar
  11. 11.
    Meyer RD, Gaultier CR, Yamashita JT, et al. Fungal sinusitis in patients with AIDS: report of 4 cases and review of the literature. Medicine. 1994;73:69–78.PubMedCrossRefGoogle Scholar
  12. 12.
    Wallace JM, Rao AV, Glassroth J, et al., and the Pulmonary Complications of HIV Infection Study Group. Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148:1523–9.PubMedGoogle Scholar
  13. 13.
    Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med. 1995;333:845–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Caiaffa WT, Viahov D, Graham NMH, et al. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increased risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med. 1994;150:1493–8.PubMedGoogle Scholar
  15. 15.
    Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Int Med. 1992;117:314–24.PubMedGoogle Scholar
  16. 16.
    Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 1992;267:1798–1805.PubMedCrossRefGoogle Scholar
  17. 17.
    Baron AD, Hollander H. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis. 1993;148:992–6.PubMedGoogle Scholar
  18. 18.
    Schuster MG, Norris AH. Community-acquired Pseudomonas aeruginosa pneumonia in patients with HIV infection. AIDS. 1994;8:1437–41.PubMedCrossRefGoogle Scholar
  19. 19.
    Jensen BN, Gerstoft J, Hojlyng N, et al. Pulmonary pathogens in HIV-infected patients. Scand J Infect Dis. 1990;22:413–20.PubMedGoogle Scholar
  20. 20.
    Masur H, Ognibene FP, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989;111:223–31.PubMedGoogle Scholar
  21. 21.
    Wheat J. Histoplasmosis and coccidioidomycosis in individuals with AIDS. A clinical review. Infect Dis Clin North Am. 1994;8:467–82.PubMedGoogle Scholar
  22. 22.
    Nightingale SD, Parks JM, Pounders SM, et al. Disseminated histoplasmosis in patients with AIDS. South Med J. 1990;83:624–30.PubMedCrossRefGoogle Scholar
  23. 23.
    Keating JJ, Rogers T, Petrou M, et al. Management of pulmonary aspergillosis in AIDS: an emerging clinical problem. J Clin Pathol. 1994;47:805–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Girardi E, Antonucci G, Armignacco O, et al. Tuberculosis and AIDS: a retrospective, longitudinal, multicentre study of Italian AIDS patients. J Infect Dis. 1994;28:261–9.Google Scholar
  25. 25.
    Chaisson RE, Schecter GF, Theuer CP, et al. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis. 1987;136:570–4.PubMedGoogle Scholar
  26. 26.
    Long R, Maycher B, Scalcini M, Manfreda J. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest. 1991;99:123–7.PubMedGoogle Scholar
  27. 27.
    Keiper MD, Beumont M, Elshami A, et al. CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. Chest. 1995;107:74–80.PubMedGoogle Scholar
  28. 28.
    Barr CE. Oral diseases in HIV-1 infection. Dysphagia. 1992;7:126–37.PubMedCrossRefGoogle Scholar
  29. 29.
    Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr. 1991;4:770–6.PubMedGoogle Scholar
  30. 30.
    Imam N, Carpenter CCJ, Mayer KH, et al. Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med. 1990;89:142–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Conant MA. Fungal infections in AIDS and other immunocompromised patients. J Am Acad Dermatol. 1994;31:S47–50.PubMedCrossRefGoogle Scholar
  32. 32.
    Drew WL, Buhles W, Erlich KS. Herpesvirus infections (cytomegalovirus, herpes simplex virus, varicella zoster virus). How to use gancyclovir (DHPG) and acyclovir. Infect Dis Clin North Am. 1988;2:495–509.PubMedGoogle Scholar
  33. 33.
    Koopman RJJ, van Merriènboer FCJ, Vreden SGS, Dolmans WMV. Molluscum contagiosum; a marker for advanced HIV infection. Br J Dermatol. 1992;126:528. Letter.PubMedCrossRefGoogle Scholar
  34. 34.
    Schwartz JJ, Myskowski PL. Molluscum contagiosum in pattents with human immunodeficiency virus infection: a review of twenty-seven patients. J Am Acad Dermatol. 1992;27:583–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Itin PH. Oral hairy leukoplakia-10 years on. Dermatology. 1993;187:159–163.PubMedCrossRefGoogle Scholar
  36. 36.
    Rosenthal D, LeBoit PE, Klumpp L, Berger TG. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol. 1991;127:206–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Khorenian SD, Lebwohl M. New cutaneous manifestations of systemic disease. Am Fam Phys. 1995;51:625–30.Google Scholar
  38. 38.
    Schatz O, Bogner JR, Goebel FD. Kaposi’s sarcoma: is the hunt for the culprit now over? J Mol Med. 1997;75(1):28–34.PubMedCrossRefGoogle Scholar
  39. 39.
    Orfanos CE, Husak R, Wölfer U, Garbe C. Kaposi’s sarcoma: a reevaluation. Recent Results Cancer Res. 1995;139:275–96.PubMedGoogle Scholar
  40. 40.
    Koehler JE, Tappero JW. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1993;17:612–24.PubMedGoogle Scholar
  41. 41.
    Bacellar H, Muñoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: multicenter AIDS cohort study, 1985–1992. Neurology. 1994;44:1892–1900.PubMedGoogle Scholar
  42. 42.
    Mariuz P, Bosler EM, Luft BJ. Toxoplasmosis in individuals with AIDS. Infect Dis Clin North Am. 1994;8:365–81.PubMedGoogle Scholar
  43. 43.
    Powderly WG, Cryptococcal meningitis and AIDS. Clin Infect Dis. 1993;17:837–42.PubMedGoogle Scholar
  44. 44.
    Pertel P, Hirschtick R, Phair J, et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 1992;5:1069–74.PubMedGoogle Scholar
  45. 45.
    Smith MA, Brennessel DJ. Cytomegalovirus. Infect Dis Clin North Am. 1994;8:427–38.PubMedGoogle Scholar
  46. 46.
    Von-Einsiedel RW, Tomiyasu U, Itabashi HH, Vinters HV. Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol. 1993;240(7):391–406.PubMedCrossRefGoogle Scholar
  47. 47.
    Mcarthur JC. Neurologic manifestations of AIDS. Medicine. 1987;6:407–35.Google Scholar
  48. 48.
    Rubin DS, Rahal JJ. Mycobacterial avium complex. Infect Dis Clin North Am. 1994;8:413–26.PubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 1998

Authors and Affiliations

  • Alan C. Jung
  • Douglas S. Paauw
    • 1
  1. 1.Department of Medicine, Box 356420, Division of General Internal MedicineUniversity of WashingtonSeattle

Personalised recommendations